CENTER ID: | NegoA.00612.a |
ORGANISM: | Neisseria gonorrhoeae NCCP11945 |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | native diffraction-data |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
I/II |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NegoA.00612.a.A11.GE43342 | full length | 1 | 503 | ||
NegoA.00612.a.A110.GE43343 | full length | 17 | 503 | ||
NegoA.00612.a.A12.GE43344 | full length | 1 | 503 | ||
NegoA.00612.a.A14.GE43346 | full length | 5 | 503 | ||
NegoA.00612.a.A15.GE43347 | full length | 7 | 503 | ||
NegoA.00612.a.A17.GE43349 | full length | 11 | 503 | ||
NegoA.00612.a.A18.GE43350 | full length | 13 | 503 | ||
NegoA.00612.a.B1.GE39969 | full length | 1 | 503 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NegoA.00612.a.B1.PW37916 | full length | 1 | 503 | ||
NegoA.00612.a.A11.PW38713 | full length | 1 | 503 | ||
NegoA.00612.a.A110.PW38714 | full length | 17 | 503 | ||
NegoA.00612.a.A12.PW38715 | full length | 1 | 503 | ||
NegoA.00612.a.A14.PW38716 | full length | 5 | 503 | ||
NegoA.00612.a.A15.PW38717 | full length | 7 | 503 | ||
NegoA.00612.a.A18.PW38718 | full length | 13 | 503 | ||
NegoA.00612.a.A17.PW38753 | full length | 11 | 503 |
METHOD | RESULTS |
---|---|
comparative modelling | Robetta_85037 |
RESOURCE | REFERENCE ID |
---|---|
PATRIC ID: | fig|521006.8.peg.1828 |
UniProt: | B4RP57 |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 60kDa |
OBSERVED MW: | 60kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 96 |
PERCENT COVERAGE: | 56 |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 58kDa |
OBSERVED MW: | 58kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 60kDa |
OBSERVED MW: | 60kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 59kDa |
OBSERVED MW: | 59kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 56 |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 59kDa |
OBSERVED MW: | 59kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 56 |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 58kDa |
OBSERVED MW: | 58kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 95 |
PERCENT COVERAGE: | 55 |
HARVESTED ON: | 7/31/2019 |
SEQUENCED ON: | 8/7/2019 |
EXPECTED MW: | 58kDa |
OBSERVED MW: | 58kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 79 |
PERCENT COVERAGE: | 73 |
HARVESTED ON: | 2/26/2016 |
SEQUENCED ON: | 3/1/2016 |
EXPECTED MW: | 58kDa |
OBSERVED MW: | 58kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Many (50-100) |
TOTAL EXPRESSION LEVEL: | High Expression |
SOLUBLE EXPRESSION LEVEL | High Expression |
EXPRESSION HOST: | data unavailable |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 70 |
PERCENT COVERAGE: | 98 |
PURIFICATION DATe: | 6/7/2016 |
CONCENTRATION: | 31mg/ml |
OBSERVED MW: | 60kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide |
EXPRESSION HOST: | data unavailable |
VIAL COUNT (approx.): | 19 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 70 |
PERCENT COVERAGE: | 98 |
PURIFICATION DATe: | 10/8/2019 |
CONCENTRATION: | 45mg/ml |
OBSERVED MW: | 60kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 14 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 96 |
PERCENT COVERAGE: | 56 |
PURIFICATION DATe: | 10/8/2019 |
CONCENTRATION: | 38.7mg/ml |
OBSERVED MW: | 58kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 19 |
VIAL VOLUME: | 25µl |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 10/9/2019 |
CONCENTRATION: | 45.5mg/ml |
OBSERVED MW: | 60kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 2 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | data unavailable |
PERCENT COVERAGE: | data unavailable |
PURIFICATION DATe: | 10/9/2019 |
CONCENTRATION: | 31.7mg/ml |
OBSERVED MW: | 59kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 8 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 56 |
PURIFICATION DATe: | 10/10/2019 |
CONCENTRATION: | 39.8mg/ml |
OBSERVED MW: | 59kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 8 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 56 |
PURIFICATION DATe: | 10/10/2019 |
CONCENTRATION: | 46.6mg/ml |
OBSERVED MW: | 58kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 6 |
VIAL VOLUME: | 23µl |
PERCENT IDENTITY: | 79 |
PERCENT COVERAGE: | 73 |
PURIFICATION DATe: | 11/10/2019 |
CONCENTRATION: | 36.7mg/ml |
OBSERVED MW: | 58kDa |
EXPRESSION LEVEL: | High Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 14 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 95 |
PERCENT COVERAGE: | 55 |